J1757 HCPCS Level II code: Injection, tividenofusp alfa-eknm, 1 mg
J1757 is the HCPCS code for “Injection, tividenofusp alfa-eknm, 1 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J1757Injection, tividenofusp alfa-eknm, 1 mg
Short description: Inj tivideno alfa-eknm 1
HCPCS · United States
Medicare details
The indicators CMS publishes with J1757 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Oct 1, 2026
Where J1757 sits
- 1J codesDrugs administered other than orally
- 2Active code J1757Injection, tividenofusp alfa-eknm, 1 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J1757 mean?
J1757 is the HCPCS code for “Injection, tividenofusp alfa-eknm, 1 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J1757?
CMS lists J1757’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J1757
All J codesJ1746Injection, ibalizumab-uiyk, 10 mgJ1747Injection, spesolimab-sbzo, 1 mgJ1748Injection, infliximab-dyyb (zymfentra), 10 mgJ1749Injection, iloprost, 0.1 mcgJ1750Injection, iron dextran, 50 mgJ1756Injection, iron sucrose, 1 mgJ1786Injection, imiglucerase, 10 unitsJ1790Injection, droperidol, up to 5 mgJ1800Injection, propranolol hcl, up to 1 mgJ1805Injection, esmolol hydrochloride, 10 mgJ1806Injection, esmolol hydrochloride (wg critical care), not therapeutically equivalent to j1805, 10 mgJ1807Injection, ethacrynate sodium, 1 mg